| Target Price | $61.20 |
| Price | $5.13 |
| Potential |
1,092.98%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Unicycive Therapeutics Inc 2026 .
The average Unicycive Therapeutics Inc target price is $61.20.
This is
1,092.98%
register free of charge
$110.25
2,049.12%
register free of charge
$30.30
490.64%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Unicycive Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Unicycive Therapeutics Inc stock has an average upside potential 2026 of
1,092.98%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Benchmark |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 29 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 08 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Nov 22 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Benchmark:
Locked
➜
Locked
|
Sep 15 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 29 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 08 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Nov 22 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


